Collateral undamage: novel arterial growth mechanism underlies neonatal heart regeneration Jan. 28, 2019
Intrabone gene therapy with autologous HSCs for transfusion-dependent beta-thalassemia: phase I/II Jan. 28, 2019
Alnylam initiates phase III trial of vutrisiran in hereditary transthyretin amyloidosis Jan. 25, 2019
Philogen opens phase II study to explore L19TNF with doxorubicin in metastatic soft tissue sarcoma Jan. 25, 2019
European Commission approves Rubraca as maintenance treatment for relapsed ovarian cancer Jan. 25, 2019
Origenis and Expansion Therapeutics to jointly discover compounds for RNA-mediated diseases Jan. 25, 2019
RSS